Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Field Trip Health Ltd. (FTRP) reports DTC eligibility
  • Securities that are eligible to be electronically cleared and settled through DTC are considered “DTC eligible.”
  • This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers
  • Field Trip is the global leader in the development and delivery of psychedelic therapies
  • Field Trip Health Ltd. (FTRP) is down 2.72 per cent and is trading at C$5.72 at 12:34 pm ET

Common shares of Field Trip Health Ltd. (FTRP) are now eligible for electronic clearing and settlement through the Depository Trust Company.

The Depository Trust Company (DTC) is a subsidiary of The Depository Trust & Clearing Corporation, a United States company that manages the electronic clearing and settlement of publicly-traded companies.

Securities that are eligible to be electronically cleared and settled through DTC are considered “DTC eligible.”

This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a wider selection of brokerage firms.

Joseph del Moral, Chief Executive Officer of Field Trip, said,

“DTC eligibility simplifies the process of transferring the Company’s shares between brokerages in the United States and speeds up the execution of trades.”

“We are pleased to become DTC eligible, which is an important step toward increasing liquidity in our stock and building a strong presence for our company within the U.S. capital markets,” added Moral.

Field Trip’s common shares and warrants continue to trade on the Canadian Securities Exchange under the tickers FTRP and FTRP.W and its common shares are posted on the OTCQX Best Board under the ticker FTRPF.

Field Trip continues to explore options to enhance liquidity and access for global investors interested in investing in Field Trip, including potential up-listings or cross-listings to the US or international exchanges and/or up-listing to senior exchanges in Canada.

Field Trip is the global leader in the development and delivery of psychedelic therapies.

With the Field Trip Discovery division leading the development of the next generation of psychedelic molecules and conducting advanced research on plant-based psychedelics including psilocybin-producing fungi, Field Trip helps people from those in treatment to those seeking accelerated personal growth.

Field Trip Health Ltd. (FTRP) is down 2.72 per cent and is trading at C$5.72 at 12:34 pm ET.

More From The Market Herald

" Marvel Biosciences (TSXV:MRVL) developing novel non-hallucinogenic neuroplastic promoting compounds

Marvel Biosciences (MRVL) has launched a program to identify and develop agents that promote neuroplasticity without the risks or side effects of psychedelics.

" Entheon Biomedical (CSE:ENBI) provides corporate update

Entheon Biomedical (ENBI) is pleased to provide an update on its operations and progress on its strategic initiatives.
Small Pharma - CEO, Peter Rands.

" Small Pharma (TSXV:DMT) granted European patent

Small Pharma (DMT) has been granted a European patent, strengthening its ketamine-based patent portfolio.

" Levitee Labs (CSE:LVT) enters into credit facility for up to $12 Million

Levitee Labs Inc. (LVT) has entered into a financing agreement for up to $12 million to fund further business expansion.